Nov 07, 2022 / 09:30PM GMT
Operator
Good afternoon. My name is Vanessa, and I will be your conference actor today. At this time, I would like to welcome everyone to the Ligand Pharmaceuticals Third Quarter 2022 Earnings Conference Call. (Operator Instructions) I would now like to turn the conference over to Simon Latimer, Head of Investor Relations. Please go ahead.
Simon Latimer - Ligand Pharmaceuticals Incorporated - Head of IR
Thank you. Welcome to Ligand's Third Quarter 2022 Financial Results and Business Update Conference Call. Speaking today for Ligand will be John Higgins, CEO; Matt Korenberg, President and COO; and Octavio Espinoza, CFO. We'll use non-GAAP financial measures, and some of our statements will be forward-looking, including those related to our financial condition, results of operations, financial guidance and the impact of the COVID-19 pandemic.
Additional information concerning risk factors and other matters concerning Ligand can be found in our earnings press release and our periodic filings with the SEC. We undertake no obligation to revise or update any
Q3 2022 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers